Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Abstract CT214: Preliminary efficacy of telisotuzumab vedotin (Teliso-V) treatment in the 2L/3L setting in MET gene amplified (MET Amp), c-Met protein overexpressing (c-Met OE), non-squamous, non-small cell lung cancer (NSQ NSCLC): retrospective analysis of LUMINOSITY
Reduces Dark Spots & Hyperpigmentation: Actively works to diminish the appearance of dark spots and pigmentation for clearer skin
Stetter and Schmid, 2020)
Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics
Resistance mechanisms to anti-EGFR therapy in RAS/RAF wildtype colorectal cancer varies by regimen and line of therapy
US$ 28.25
US$ 20.45
US$ 29.59
US$ 23.99
US$ 23.01
US$ 28.73
